Derma and La Prairie support Beiersdorf

In the third quarter of 2026, Beiersdorf generated €2.4 billion in sales, down 1.3% organically. Performance remained mixed across its brands: the Derma business, driven by Eucerin and Aquaphor, grew 10.6%, while La Prairie accelerated to +8.5%, supported notably by China. By contrast, Nivea was still down 4.9%, although sales dynamics improved versus the second quarter.

Within Derma, Beiersdorf highlighted Aquaphor’s expansion into body care and the launch of Eucerin Dermopure Clinical Probiom8, based on the patented TopiC.A^™ active and microbiome research. La Prairie benefited from the launch of Swiss Pristine, while Nivea continued its turnaround plan with initiatives including Face+ in Europe.

For the first nine months of the year, Group sales reached €7.3 billion, down 2.8% organically. Beiersdorf nevertheless confirmed its 2026 guidance.